{"id":1022599,"date":"2026-11-19T08:23:06","date_gmt":"2026-11-19T13:23:06","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/harmony-biosciences-to-participate-in-upcoming-investor-conferences-4\/"},"modified":"2026-11-19T08:23:06","modified_gmt":"2026-11-19T13:23:06","slug":"harmony-biosciences-to-participate-in-upcoming-investor-conferences-4","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/harmony-biosciences-to-participate-in-upcoming-investor-conferences-4\/","title":{"rendered":"Harmony Biosciences to Participate in Upcoming Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p>PLYMOUTH MEETING, Pa., Nov.  19, 2026  (GLOBE NEWSWIRE) &#8212; Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced that Harmony&#8217;s management team will participate in the following upcoming investor conferences.<\/p>\n<p>\n        <strong>9<\/strong><br \/>\n        <sup><br \/>\n          <strong>th<\/strong><br \/>\n        <\/sup><br \/>\n        <strong> Annual Evercore Healthcare Conference<\/strong>\n      <\/p>\n<ul type=\"disc\">\n<li>Location: Miami, FL<\/li>\n<li>Fireside Chat: November 30, 2026, at 4:15 p.m. ET<\/li>\n<li>One-on-One Investor Meetings: December 1, 2026<\/li>\n<\/ul>\n<p>\n        <strong>Piper Sandler 38<\/strong><br \/>\n        <sup><br \/>\n          <strong>th<\/strong><br \/>\n        <\/sup><br \/>\n        <strong> Annual Healthcare Conference<\/strong>\n      <\/p>\n<ul type=\"disc\">\n<li>Location: New York, NY<\/li>\n<li>Fireside Chat: December 3, 2026, at 11:00 a.m. ET<\/li>\n<\/ul>\n<p>Webcasts of the fireside chats will be available on the investor page of the Harmony Biosciences website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=g-mAvCs6rQe_R93Ct2_IWpSZVzcRTWBchMbkTauZunNLM_2Q7fYsyN5ghPJQ8gS--dotRLzKhjzElRMVOFtIZ-q6tHLDUgQQnOlTTqrfnW0SQPNmPpDMzeSFTVNWgWSKQHGKNpsgV4TZOKWX-X03ZlqOVOV8yoesPTOpsQ9VjNmdsB_Qmf-x6mqe6Dj5D-r7CujzHIikOE81kWQxvLkrhMjGerNDRHja2Nf9CHECWjB68ZtQGXYElzrFeea28n2nJZh0JEEDyL78F9Tu6DfUJ0Zp7o4z3Meb09hKl2qTmEBK2krSmQi0bigp4yYdqR0JNROmk3t9QxJN8rg5tT_gzpcgKTZZEPOzZYRpGxf9EG7PesSETQ4ABvSToWNA2UhSHjRsv6LfHQgEO6FJoOMD6A==\" rel=\"nofollow\" target=\"_blank\">https:\/\/ir.harmonybiosciences.com\/<\/a>.<\/p>\n<p>\n        <strong>About Harmony Biosciences<\/strong><br \/>\n        <br \/>Harmony Biosciences is developing and commercializing innovative medicines for both rare and broad CNS disorders, and we are becoming an enduring leader in neuroscience. Our first medicine, WAKIX\u00ae (pitolisant), is the first and only FDA-approved non-scheduled treatment for excessive daytime sleepiness or cataplexy in patients 6 years of age and older with narcolepsy. Its launch ranks among the most successful in the history of orphan drugs. Building on our success and profitability, we are continuing to advance our novel clinical-stage pipeline, led by BP-205, an investigational orexin-2 receptor agonist with best-in-class potential across a broad range of CNS disorders. With a strong balance sheet, we have the capacity and conviction to pursue strategic business development opportunities. Harmony is guided by an unwavering commitment to patients and driven to create long-term value for shareholders. For more information, visit: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=_-A3FWkYf-DxzljRoCDGHjvWxZhjWge7xqzEJaHle7pzirM_-TVmKYXpeAdXOvSVDC1UJpq-AufvsGHXIiG_dLwgFvtyleyR6N9gAkVcs3BFIopiQN3HTwl5An-JSAMxvAPOa9wSdqP9NgvzDRGmAOVjYYQPbwtLxm0-WXj1FZOgj_TDbTgkwDdmvEzW01lvPptyVyOKhOeQxKrGncf54Qh6QcV2mCHADjJvF01zXUnOKsHqGMeDiinGE9l9RJDJARW0Dk3idsU_hDNBpsLkfPXphm4BSs2MlgMUFe8Kg3GsZj5uoeLQnOnUhYcAR9MQqzRs6DTmmOmBVksidrG0ZEompacnYPa72VZ72GProvmuufvFXeWSWmQNNfizTL3uEvUhRvyoNcFqXFizQK-55HlrBvLK5rGcTEokfzDR-MI=\" rel=\"nofollow\" target=\"_blank\">www.harmonybiosciences.com<\/a>.<\/p>\n<p>\n        <strong>Harmony Biosciences Investor Contact:<\/strong><br \/>\n        <br \/>Brennan Doyle<br \/>484-566-3685<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=U6VXBGcFgsA3lFS5_FBX0eY_9jNCWQiuFQSUJpbtw5smzduOr4dIS_AjUZppC4kbUpu6o08Okh1Nprh5qHylvVVG9uFI-5dCJO3-uVjH2hKF7TgbOjXoC9hvAGi33Rab\" rel=\"nofollow\" target=\"_blank\">bdoyle@harmonybiosciences.com<\/a><\/p>\n<p>\n        <strong>Harmony Biosciences Media Contact:<\/strong><br \/>\n        <br \/>Cate McCanless<br \/>202-641-6086<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Da_qAc7gQHzS23SjnHUQ5VWveoV-dNjBFYteLbBvURUlj-dh1muXUyTp9Fg135cgDsvJBcpKmByFE0iSCJI0qJrhLTO0aznxR-Ww2Nu8y9ocF5c4x4BkS3j0hJHNCg7GlR3XZrZQ5whpd7jT90o-bw==\" rel=\"nofollow\" target=\"_blank\">cmccanless@harmonybiosciences.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg4MDgyOCM3OTc0MjIyIzIyMDE1NTM=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MDdkOTNjMGItMzgwMC00ZDMyLThkNGEtOTY4ZjgyODFhMWEyLTEyMTMxMDYtMjAyNi0xMS0xOS1lbg==\/tiny\/Harmony-Biosciences.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>PLYMOUTH MEETING, Pa., Nov. 19, 2026 (GLOBE NEWSWIRE) &#8212; Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced that Harmony&#8217;s management team will participate in the following upcoming investor conferences. 9 th Annual Evercore Healthcare Conference Location: Miami, FL Fireside Chat: November 30, 2026, at 4:15 p.m. ET One-on-One Investor Meetings: December 1, 2026 Piper Sandler 38 th Annual Healthcare Conference Location: New York, NY Fireside Chat: December 3, 2026, at 11:00 a.m. ET Webcasts of the fireside chats will be available on the investor page of the Harmony Biosciences website at https:\/\/ir.harmonybiosciences.com\/. About Harmony Biosciences Harmony Biosciences is developing and commercializing innovative medicines for both rare and broad CNS disorders, and we are becoming an enduring leader in neuroscience. Our &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/harmony-biosciences-to-participate-in-upcoming-investor-conferences-4\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Harmony Biosciences to Participate in Upcoming Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1022599","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Harmony Biosciences to Participate in Upcoming Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/harmony-biosciences-to-participate-in-upcoming-investor-conferences-4\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Harmony Biosciences to Participate in Upcoming Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PLYMOUTH MEETING, Pa., Nov. 19, 2026 (GLOBE NEWSWIRE) &#8212; Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced that Harmony&#8217;s management team will participate in the following upcoming investor conferences. 9 th Annual Evercore Healthcare Conference Location: Miami, FL Fireside Chat: November 30, 2026, at 4:15 p.m. ET One-on-One Investor Meetings: December 1, 2026 Piper Sandler 38 th Annual Healthcare Conference Location: New York, NY Fireside Chat: December 3, 2026, at 11:00 a.m. ET Webcasts of the fireside chats will be available on the investor page of the Harmony Biosciences website at https:\/\/ir.harmonybiosciences.com\/. About Harmony Biosciences Harmony Biosciences is developing and commercializing innovative medicines for both rare and broad CNS disorders, and we are becoming an enduring leader in neuroscience. Our &hellip; Continue reading &quot;Harmony Biosciences to Participate in Upcoming Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/harmony-biosciences-to-participate-in-upcoming-investor-conferences-4\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-19T13:23:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg4MDgyOCM3OTc0MjIyIzIyMDE1NTM=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/harmony-biosciences-to-participate-in-upcoming-investor-conferences-4\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/harmony-biosciences-to-participate-in-upcoming-investor-conferences-4\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Harmony Biosciences to Participate in Upcoming Investor Conferences\",\"datePublished\":\"2026-11-19T13:23:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/harmony-biosciences-to-participate-in-upcoming-investor-conferences-4\\\/\"},\"wordCount\":258,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/harmony-biosciences-to-participate-in-upcoming-investor-conferences-4\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg4MDgyOCM3OTc0MjIyIzIyMDE1NTM=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/harmony-biosciences-to-participate-in-upcoming-investor-conferences-4\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/harmony-biosciences-to-participate-in-upcoming-investor-conferences-4\\\/\",\"name\":\"Harmony Biosciences to Participate in Upcoming Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/harmony-biosciences-to-participate-in-upcoming-investor-conferences-4\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/harmony-biosciences-to-participate-in-upcoming-investor-conferences-4\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg4MDgyOCM3OTc0MjIyIzIyMDE1NTM=\",\"datePublished\":\"2026-11-19T13:23:06+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/harmony-biosciences-to-participate-in-upcoming-investor-conferences-4\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/harmony-biosciences-to-participate-in-upcoming-investor-conferences-4\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/harmony-biosciences-to-participate-in-upcoming-investor-conferences-4\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg4MDgyOCM3OTc0MjIyIzIyMDE1NTM=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg4MDgyOCM3OTc0MjIyIzIyMDE1NTM=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/harmony-biosciences-to-participate-in-upcoming-investor-conferences-4\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Harmony Biosciences to Participate in Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Harmony Biosciences to Participate in Upcoming Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/harmony-biosciences-to-participate-in-upcoming-investor-conferences-4\/","og_locale":"en_US","og_type":"article","og_title":"Harmony Biosciences to Participate in Upcoming Investor Conferences - Market Newsdesk","og_description":"PLYMOUTH MEETING, Pa., Nov. 19, 2026 (GLOBE NEWSWIRE) &#8212; Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced that Harmony&#8217;s management team will participate in the following upcoming investor conferences. 9 th Annual Evercore Healthcare Conference Location: Miami, FL Fireside Chat: November 30, 2026, at 4:15 p.m. ET One-on-One Investor Meetings: December 1, 2026 Piper Sandler 38 th Annual Healthcare Conference Location: New York, NY Fireside Chat: December 3, 2026, at 11:00 a.m. ET Webcasts of the fireside chats will be available on the investor page of the Harmony Biosciences website at https:\/\/ir.harmonybiosciences.com\/. About Harmony Biosciences Harmony Biosciences is developing and commercializing innovative medicines for both rare and broad CNS disorders, and we are becoming an enduring leader in neuroscience. Our &hellip; Continue reading \"Harmony Biosciences to Participate in Upcoming Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/harmony-biosciences-to-participate-in-upcoming-investor-conferences-4\/","og_site_name":"Market Newsdesk","article_published_time":"2026-11-19T13:23:06+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg4MDgyOCM3OTc0MjIyIzIyMDE1NTM=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/harmony-biosciences-to-participate-in-upcoming-investor-conferences-4\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/harmony-biosciences-to-participate-in-upcoming-investor-conferences-4\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Harmony Biosciences to Participate in Upcoming Investor Conferences","datePublished":"2026-11-19T13:23:06+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/harmony-biosciences-to-participate-in-upcoming-investor-conferences-4\/"},"wordCount":258,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/harmony-biosciences-to-participate-in-upcoming-investor-conferences-4\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg4MDgyOCM3OTc0MjIyIzIyMDE1NTM=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/harmony-biosciences-to-participate-in-upcoming-investor-conferences-4\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/harmony-biosciences-to-participate-in-upcoming-investor-conferences-4\/","name":"Harmony Biosciences to Participate in Upcoming Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/harmony-biosciences-to-participate-in-upcoming-investor-conferences-4\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/harmony-biosciences-to-participate-in-upcoming-investor-conferences-4\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg4MDgyOCM3OTc0MjIyIzIyMDE1NTM=","datePublished":"2026-11-19T13:23:06+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/harmony-biosciences-to-participate-in-upcoming-investor-conferences-4\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/harmony-biosciences-to-participate-in-upcoming-investor-conferences-4\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/harmony-biosciences-to-participate-in-upcoming-investor-conferences-4\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg4MDgyOCM3OTc0MjIyIzIyMDE1NTM=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg4MDgyOCM3OTc0MjIyIzIyMDE1NTM="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/harmony-biosciences-to-participate-in-upcoming-investor-conferences-4\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Harmony Biosciences to Participate in Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1022599","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1022599"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1022599\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1022599"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1022599"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1022599"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}